Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.085
-0.055 (-4.81%)
May 18, 2026, 10:51 AM EDT - Market open
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $96.97 million as of May 18, 2026. Its market cap has increased by 249.87% in one year.
Market Cap
96.97M
Enterprise Value
65.69M
1-Year Change
249.87%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $96.97M, a decrease of -62.19%. That is a compound annual growth rate of -19.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 101.86M | -14.52% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PepGen | 107.21M |
| Q32 Bio | 106.83M |
| Inovio Pharmaceuticals | 106.52M |
| LeonaBio | 105.77M |
| Aldeyra Therapeutics | 101.34M |
| Vivani Medical | 100.90M |
| Cibus | 99.93M |
| Aardvark Therapeutics | 99.70M |